Access Investment Management LLC Acquires Shares of 194,715 Integra LifeSciences Holdings Co. (NASDAQ:IART)

Access Investment Management LLC acquired a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 194,715 shares of the life sciences company’s stock, valued at approximately $4,416,000. Integra LifeSciences comprises 1.3% of Access Investment Management LLC’s investment portfolio, making the stock its 28th biggest holding. Access Investment Management LLC owned 0.25% of Integra LifeSciences as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also bought and sold shares of the company. KBC Group NV lifted its position in Integra LifeSciences by 65.2% during the third quarter. KBC Group NV now owns 2,839 shares of the life sciences company’s stock valued at $52,000 after purchasing an additional 1,120 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in Integra LifeSciences by 599.6% during the fourth quarter. Nisa Investment Advisors LLC now owns 3,267 shares of the life sciences company’s stock valued at $74,000 after purchasing an additional 2,800 shares during the last quarter. Empowered Funds LLC bought a new position in Integra LifeSciences during the fourth quarter valued at $180,000. Centiva Capital LP bought a new position in Integra LifeSciences during the third quarter valued at $192,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Integra LifeSciences in the third quarter valued at $198,000. Institutional investors own 84.78% of the company’s stock.

Integra LifeSciences Trading Down 4.1 %

IART stock opened at $21.13 on Friday. The company has a market capitalization of $1.63 billion, a PE ratio of -234.75, a P/E/G ratio of 0.73 and a beta of 1.17. Integra LifeSciences Holdings Co. has a 12 month low of $16.81 and a 12 month high of $45.11. The firm’s 50-day moving average is $23.71 and its 200 day moving average is $21.81. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.20 and a quick ratio of 0.73.

Wall Street Analyst Weigh In

IART has been the topic of several recent analyst reports. Morgan Stanley initiated coverage on shares of Integra LifeSciences in a research note on Monday, December 2nd. They issued an “underweight” rating and a $20.00 target price on the stock. Citigroup increased their target price on shares of Integra LifeSciences from $16.00 to $22.00 and gave the company a “sell” rating in a research note on Tuesday, November 5th. Three analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Integra LifeSciences presently has a consensus rating of “Hold” and an average price target of $23.00.

Insider Buying and Selling

In related news, EVP Michael J. Mcbreen sold 1,700 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $24.16, for a total value of $41,072.00. Following the transaction, the executive vice president now owns 56,182 shares of the company’s stock, valued at $1,357,357.12. This trade represents a 2.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 3.10% of the stock is currently owned by insiders.

Integra LifeSciences Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.